Is i3 Pharmaceuticals, LLC FDA approved?

i3 Pharmaceuticals, LLC holds no registered establishment of its own; 19 drug products are listed under its name in the National Drug Code Directory, made at sites registered to other firms.

What drugs does i3 Pharmaceuticals, LLC make?

19 products are listed under i3 Pharmaceuticals, LLC in the openFDA NDC Directory, most often as tablet; tablet, film coated; tablet, film coated, extended release. The full breakdown by dosage form and route is above. A listing count is not a sales figure.

i3 Pharmaceuticals, LLC

Data as of 24 Sept 2026 · How to read this entry

Request a quote Claim this profile

Registered sites: 0
Active NDC listings: 19
Live patents: 0
Countries: 0

Catalogue

Drug listings by form and route

19 active NDC listings: 19 human prescription drug. By marketing category: ANDA 19.

Dosage form	NDCs
tablet	10
tablet, film coated	4
tablet, film coated, extended release	2
capsule	1
solution	1
tablet, delayed release	1

Route	NDCs
oral	18
topical	1

Labeller name on the listing	NDCs
i3 pharmaceuticals, llc	19

Catalogue

Marketed products

Brand	Generic name	Form / route	NDC
Clindamycin phosphate	Clindamycin phosphate topical	solution, topical	72319-696ANDA
Everolimus	everolimus	tablet, oral	72319-003ANDA
Everolimus	everolimus	tablet, oral	72319-015ANDA
Everolimus	everolimus	tablet, oral	72319-016ANDA
Everolimus	everolimus	tablet, oral	72319-017ANDA
Guanfacine	Gaunfacine	tablet, oral	72319-018ANDA
Guanfacine	Gaunfacine	tablet, oral	72319-019ANDA
METHSCOPOLAMINE BROMIDE	methscopolamine bromide	tablet, oral	72319-029ANDA
METHSCOPOLAMINE BROMIDE	methscopolamine bromide	tablet, oral	72319-030ANDA
Maraviroc	Maraviroc	tablet, film coated, oral	72319-024ANDA
Maraviroc	Maraviroc	tablet, film coated, oral	72319-025ANDA
Posaconazole	Posaconazole	tablet, delayed release, oral	72319-023ANDA
RANOLAZINE	RANOLAZINE	tablet, film coated, extended release, oral	72319-021ANDA
RANOLAZINE	RANOLAZINE	tablet, film coated, extended release, oral	72319-022ANDA
Ramelteon	Ramelteon	tablet, film coated, oral	72319-005ANDA
Rifabutin	Rifabutin	capsule, oral	72319-010ANDA
Selegiline Hydrochloride	Selegiline Hydrochloride	tablet, oral	72319-006ANDA
Tranexamic Acid	Tranexamic Acid	tablet, oral	72319-028ANDA
isosorbide dinitrate and hydralazine hydrochloride	isosorbide dinitrate and hydralazine hydrochloride	tablet, film coated, oral	72319-012ANDA

Compare

Other companies listing everolimus

Novartis Pharmaceuticals Corporation20 sites · 210 NDC
Biocon Biologics Limited9 sites · 176 NDC
Aurobindo Pharma Limited6 sites · 1,453 NDC
Novugen Pharma Sdn. Bhd.1 site · 27 NDC
Amneal Pharmaceuticals NY LLC0 sites · 337 NDC
NorthStar RxLLC0 sites · 302 NDC
Novartis Pharma Stein AG0 sites · 39 NDC

Enquiry

Common questions

Is i3 Pharmaceuticals, LLC FDA approved?: i3 Pharmaceuticals, LLC holds no registered establishment of its own; 19 drug products are listed under its name in the National Drug Code Directory, made at sites registered to other firms.
What drugs does i3 Pharmaceuticals, LLC make?: 19 products are listed under i3 Pharmaceuticals, LLC in the openFDA NDC Directory, most often as tablet; tablet, film coated; tablet, film coated, extended release. The full breakdown by dosage form and route is above. A listing count is not a sales figure.

Compiled from FDA establishment registrations, the openFDA NDC Directory, the Orange Book and the FDA drug shortage database. Not claimed by the company. Sources and methodology.